SEC Form 4 · accession 0001140361-15-026571
Asterias Biotherapeutics, Inc. · AST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Wirth
Officer — Chief Medical Officer
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001572552
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Jun 30, 2015 | F | 1,668 | $4.60 | D | 2,880 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported herein are being withheld by the Issuer in connection with the payment of applicable taxes upon the vesting of 4,548 RSUs granted on February 13, 2015. Such shares will be held by the Issuer as treasury stock.